Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Free Report) COO Jeffrey Edward Nelson sold 12,245 shares of the firm’s stock in a transaction that occurred on Monday, January 26th. Jeffrey Edward Nelson also recently made the following trade(s):Get Milestone Pharmaceuticals alerts:On Monday, December 15th, Jeffrey Edward Nelson sold 58,007 shares of Milestone Pharmaceuticals stock. Milestone Pharmaceuticals Price PerformanceMilestone Pharmaceuticals stock traded down $0.07 during mid-day trading on Wednesday, reaching $1.94. View Our Latest Stock Analysis on Milestone PharmaceuticalsMore Milestone Pharmaceuticals NewsHere are the key news stories impacting Milestone Pharmaceuticals this week:Milestone Pharmaceuticals Company Profile(Get Free Report)Milestone Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for respiratory diseases. Read MoreReceive News & Ratings for Milestone Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.